Pharmaceutical market in the Netherlands - Statistics & Facts

The Dutch pharmaceutical market is currently generating revenues of some 5.1 billion euros within basic health insurance coverage. With this amount it represents one of the mid-sized national markets among EU-countries. Pharmaceutical expenditures are the second largest category among total health care costs in the Netherlands, only topped by medical specialized care. Health care expenditures in the Netherlands total almost 52 billion euros (while by the broader definition – including long-term treatment, welfare, social services and child care – these costs are even twice as high).

In a phase of recovery

The Dutch health market in general saw a significant recovery in the volume of health goods already in the second pandemic year of 2021. Expenditures in most of the main health segments were reported to have grown. As of 2023, pharmaceutical revenues in the Netherlands within basic health insurance coverage have exceeded five billion euros for the first time since 2011.

Independent pharmacies are top

Like in most countries, the Dutch pharmaceutical market is dominated by pharmacies as the major distribution channel. In the Netherlands, the number of public pharmacies has been almost the same over the last five years, with only slight fluctuations. Most pharmacies in the country are independent, while around a third are owned by larger chains. As of 2023, of nearly two thousand pharmacies, 1,063 were independent. Average pharmacy costs per person under the Dutch Health Insurance Act came to 277 euros in 2021, significantly lower than in the years before 2012.

The consumer’s side

When it comes to the consumer side, omeprazole was the third most used drug in the Netherlands during 2022. Some 1.23 million Dutch used the proton pump inhibitor (PPI) to treat symptoms of the gastroesophageal reflux disease. Based on expenditures, the leading drug in 2022 was anticoagulant apixaban, sold under the brand name Eliquis. In general, there is a decreasing trend in dispensed medicines among some major therapeutic classes in the Netherlands like, for example, antidepressants, analgesics, and respiratory medicines. The self-medication market in the Netherlands is substantial, generating revenues totaling around 912 million euros, with vitamins and minerals representing the largest single chunk, followed by respiratory products and pain relief remedies.
This text provides general information. Statista assumes no liability for the information given being complete or correct. Due to varying update cycles, statistics can display more up-to-date data than referenced in the text.
Published by Statista Research Department, Feb 12, 2024

Key insights

Expenditure growth for medicines in the Netherlands in 2021
-1.4%
Estimated pharmaceutical revenue within the Dutch basic health insurance coverage in 2022
5.08 bn EUR
Projected pharmaceutical care costs in the Netherlands in 2023
5.3 bn EUR
Get more insights

Editor’s Picks Current statistics on this topic

Total healthcare costs in the Netherlands in 2023, by type of care (in million euros)

Health Economics

Total healthcare costs in the Netherlands 2023, by care type

Leading medicines with the highest expenditure in the Netherlands in 2022 (in million euros)

Pharmaceuticals

Medicines with the highest expenditure in the Netherlands 2022

Number of dispensed antidepressants in the Netherlands from 2014 to 2022

Pharmaceuticals

Dispensed antidepressants in the Netherlands 2014-2022

Related topics

Recommended

4

Recommended statistics

Healthcare costs

4

Healthcare costs

Market overview

5

Market overview

Pharmacies

5

Pharmacies

Select therapeutic areas

4

Select therapeutic areas

Self-medication

5

Self-medication

Further reportsGet the best reports to understand your industry

Pharmaceutical trends in Europe
Pharmaceutical trends in Europe
Pharmaceutical industry in Denmark
Pharmaceutical industry in Denmark
Pharmaceutical market in Norway
Pharmaceutical market in Norway
Pharmaceutical market in Sweden
Pharmaceutical market in Sweden
Pharmaceutical industry in Scandinavia
Pharmaceutical industry in Scandinavia

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)
Email
support@statista.com

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)
Email
asia.support@statista.com

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)
Email
asia.support@statista.com

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)
Email
eu.support@statista.com

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)
Email
latam@statista.com

Mon - Fri, 9am - 6pm (EST)

Menu